Medicenna Therapeutics Corp. (MDNA) Tops Q1 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts MDNA Hot Sheet
Join SI Premium – FREE
Medicenna Therapeutics Corp. (NASDAQ: MDNA) reported Q1 EPS of ($0.04), $0.02 better than the analyst estimate of ($0.06).
For earnings history and earnings-related data on Medicenna Therapeutics Corp. (MDNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kosmos Energy (KOS) Misses Q3 EPS by 3c
- Republic Services (RSG) PT Lowered to $270 at Wells Fargo
- Enterprise Products Partners (EPD) PT Raised to $39 at Goldman Sachs
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
